A comprehensive view of ethylene vinyl acetate (eva). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.
Celanese highlights its VitalDose EVA in the newly launched iDose TR glaucoma treatment by Glaukos; VitalDose EVA provides sustained drug release, aiding in 24/7 drug levels over a sustained time period to improve patient compliance
Published:
March 01, 2024
by Business Wire
|
Dow Global Technologies LLC and Rohm and Haas Co File Patent Application for Acrylic-Based Adhesive Composition with Ethylene Vinyl Acetate
Published:
February 29, 2024
by Indian Patents News
|
US Patent Issued to Bostik on Feb. 27 for "Hot melt adhesive containing a hydrogenated styrenic block copolymer and an ethylene vinyl acetate copolymer exhibiting low blocking force" (Wisconsin Inventors)
Published:
February 28, 2024
by U.S. Fed News
|
US Patent Issued to NOVA Chemicals (International) on Feb. 6 for "Process to produce ethylene and vinyl acetate monomer and derivatives thereof" (Canadian Inventors)
Published:
February 07, 2024
by U.S. Fed News
|
Braskem appoints FKuR as a logistics and marketing support partner for the 'I’m green' branded bio-based EVA in EU, Switzerland, Norway, UK, Turkey, Israel and India
Published:
January 29, 2024
by Renewable Carbon Initiative (RCI)
|
Ask us about our Chemicals Industry market view